Hyperlipidemia Flashcards

1
Q

How is the atherosclerotic cardiovascular disease (ASCVD) risk calculated?

A

Using the Pooled Cohort Equations risk calculator.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When are children/young adults screened for dyslipidemia?

A

9 to 11 and then again 17 to 21.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

For average/low risk patients, what is the interval for surveillance for dyslipidemia?

A

every 4 to 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Males are screened for dyslipidemia starting at what age?

A

35 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Females are screened for dyslipidemia starting at what age?

A

45 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

This patient has established atherosclerotic cardiovascular disease (ASCVD) based on her previous myocardial infarction. Patients with known ASCVD are at high risk for future cardiovascular events and death. Several randomized trials for secondary prevention of ASCVD have shown significant risk reduction in cardiovascular events and overall cardiovascular disease mortality in patients treated with statins.
Current guidelines recommend high-intensity statin therapy (eg, atorvastatin 40-80 mg, rosuvastatin 20-40 mg daily) for secondary prevention in all patients age s75 with known ASCVD (moderate-intensity statin therapy is recommended for those age >75), regardless of baseline LDL level.
Statin therapy is also recommended for primary prevention of ASCVD in patients with serum LDL
≥190 mg/dL, age ≥40 with diabetes mellitus, or with an estimated 10-year risk of ASCVD
>7.5%-10% (guidelines vary on the exact cutoff) using the Pooled Cohort Equations risk calculator.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the risks of TAGs, LDL, and HDL?

A

Elevated levels of LDL are known to be atherogenic, while HDL is anti-atherogenic. Triglycerides do not have clear association with atherosclerosis, but at very high levels (> 1000) are associated with pancreatitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hyperlipidemia increases the risk of … ?

A

Risk factor for coronary disease and stroke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lipid deposits can lead to … ?

A

“xanthelasma,” lipid deposit, commonly of tendon and eyelid.

Corneal arcus (lipid deposit in cornea).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the lifestyle modifications for all patients with hyperlipidemia?

A
  • Healthy diet
    -Exercise
    -Quit smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What comorbid condition accelerates atherosclerotic cardiovascular disease (ASCVD) the worst?

A

diabetes > smoking > hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What comorbid condition accelerates atherosclerotic cardiovascular disease (ASCVD) most commonly?

A

hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Patients between 40 to 75 who are high risk (DM, smoking, HTN, family history) are managed for atherosclerotic cardiovascular disease by … ?

A

Getting a statin regardless of LDL levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the primary preventive measures for statin therapy?

A

LDL > 190 → High intesity statin
40 to 75 years old with DM → Moderate to High intensity statin
ASCVD risk greater than 7.5% to 10% → Moderate to High statin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When a patient has known ASCVD (CAD, CVA, PAD) what is the measure to manage their dyslipidemia?

A

They will get a “Secondary Prevention,” which is a High intensity statin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the high intensity statins?

A

High-intensity statins:
- Atorvastatin 40-80 mg
- Rosuvastatin 20-40 mg;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the moderate-intensity statins?

A

Moderate-intensity statins:
- Atorvastatin 10-20 mg
- Rosuvastatin 5-10 mg
- Simvastatin 20-40 mg
- Pravastatin 40-80 mg
- Lovastatin 40 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the MOA of statin therapy?

A

HMG-CoA inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Once starting statins, what must be done before initiation of treatment and is there a reason to monitor patients?

A

Obtain baseline LFTs and CK, but no need to screen for LFTs/CK unless symptomatic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the effect of statin on LDL, HDL, and Trig?

A

Lowers LDL, increases HDL, Lowers Trig.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the adverse effects of statin therapy?

A

Hepatotoxicity (most common), rhabdomyolysis, and myopathy (least common).

22
Q

If patient develops myalgias or transaminitis on statins, what is the first course of action?

A

stop drug, retry at lower dose.

23
Q

What medication can be used to bind fats in the GI for hyperlipidemia?

A

Bile Resins such as Cholestyramine or Colestipol.

24
Q

What effect doest Cholestyramine or Colestipol have on LDLs, HDLs, and Trig?

A

These will lower LDL, raise HDL, but have no impact on trigs.

25
Q

What are the adverse affects of Cholestyramine or Colestipol?

A

GI necrosis, malabsorption, GI disturbances, and drug malabsorption.

26
Q

When can ezetimibe be considered for patients with hyperlipidemia?

A

If patient extremely high risk and LDL remains > 70-100 mg/dL.

27
Q

What is the MOA of ezetimibe?

A

Inhibits cholesterol absorption (NPCILI).

28
Q

What effect does ezetimibe have on LDLs, HDLs, and Trig?

A

Only lowers LDL.

29
Q

What is the major adverse reaction with ezetimibe therapy?

A

Diarrhea

30
Q

Gemfibrozil and Fenofibrate are fibrates that … ?

A

upregulate LPL and activate PPAR-a

31
Q

Gemfibrozil and Fenofibrate have on LDLs, HDLs, and Trig?

A

These will incresae HDL and decrease trigs.

32
Q

What are the significant adverse reactions of fibrates?

A

First, these can’t be given with statins.

vvvvvvvvvv

They increase the occurance of gallstones.

vvvvvvvvvv

Gemfibrozil is known to cause myositis.

33
Q

Niacin has what MOA?

A

Inhibits lipolysis

34
Q

What effect does niacin have on LDLs, HDLs, and Trig?

A

Lowers LDL, raises HDL and Lowers Trigs.

35
Q

Does niacin improve the overall cardiovascular outcomes, especially for patients who have experienced a previous MI?

A

Niacin (ie, nicotinic acid) is effective in increasing HDL levels and has modest effects in reducing LDL levels. However, despite the favorable effects on lipid profile, niacin has not shown improvement in cardiovascular outcomes in patients with known ASCVD.

36
Q

What are the adverse reactions with use of niacin?

A

Flushing (use ASA), Hyperglycemia, uricemia

37
Q

What is the MOA of Omega-3 fatty acids for hyperlididemia?

A

Decreases hepatic fat secretion.

38
Q

What effect does Omega-3 have on LDLs, HDLs, and Trig?

A

raises HDL and lowers LDL.

39
Q

When can PCSK-9 inhibitors (Evolocumab or Alirocumab) be considered for patients with hyperlipidemia?

A

If patient extremely high risk and LDL remains > 70-100 mg/dL.

40
Q

What is the MOA of PCSK-9 inhibitors (Evolocumab or Alirocumab)?

A

Prevents LDL-R uptake/breakdown

41
Q

What effect do PCSK-9 inhibitors (Evolocumab or Alirocumab) have on LDLs, HDLs, and Trig?

A

Lowes LDL, raises HDL, lowers trigs

42
Q

What is the main adverse reactions of PCSK-9 inhibitors (Evolocumab or Alirocumab)?

A

Reaction at injection site.

43
Q

When triglycerides are elvated (in isolation), what is used to drive management?

A

Whether TGs are between 15 to 500 mg/dL or above 500 mg/dL.

44
Q

LPL deficiency is caused by an autosomal _________ genetic cause for hyperlidemia?

A

autosomal recessive

vvvvvvvvvvv

Class I dyslipemia (Hyperchylomicronemia)

45
Q

LPL deficiency leads to an increase of …. ?

A

Increases TG → Pancreatitis

46
Q

LDL-R deficiency is caused by an autosomal _________ genetic cause for hyperlidemia?

A

autosomal dominant

vvvvvvvvvvv

Class IIa dyslipemia (Hypercholesterolemia)

47
Q

LDL-R deficiency leads to an increase of …. ?

A

Increases LDL → Severe atherosclerosis

48
Q

APO-E mutation is caused by an autosomal _________ genetic cause for hyperlidemia?

A

autosomal recessive

vvvvvvvvvvv

Class III dyslipemia (Dysbetalipoproteinemia)

49
Q

APO-E mutation leads to an increase of … ?

A

Choesterol and TGs → Premature CAD

50
Q

VLDL overproduction is caused by an autosomal _________ genetic cause for hyperlidemia?

A

autosomal dominant

vvvvvvvvvvv

Class IV dyslipemia

51
Q

VLDL overproduction leads to an increase in … ?

A

Increases TG and VLDL → Premature CAD